Back to top
more

Waters (WAT)

(Real Time Quote from BATS)

$306.78 USD

306.78
264,296

-6.52 (-2.08%)

Updated Apr 24, 2024 02:17 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. Waters Division (88.8% of total revenues in 2019) - High Performance and Ultra Performance Liquid Chromatography (HPLC and UPLC). TA Division (11.2% of total revenues in 2019)- Thermal Analysis, Rheometry and Calorimetry.

Waters (WAT) Boosts Waters Operating Segment With HPLC System

by Zacks Equity Research

Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.

LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?

by Zacks Equity Research

LivaNova (LIVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Waters (WAT) Boosts PFAS Testing Solutions With New Cartridges

by Zacks Equity Research

Waters (WAT) launches Oasis WAX/GCB and GCB/WAX Cartridges for PFAS testing, thus boosting the Waters Operating segment.

Waters (WAT) Boosts Portfolio Strength With Rheo-IS Accessory

by Zacks Equity Research

Waters (WAT) unveils Rheo-IS accessory for its TA Instruments Discovery Hybrid Rheometers, bolstering its overall portfolio.

Why Is Waters (WAT) Up 7.9% Since Last Earnings Report?

by Zacks Equity Research

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Waters (WAT) Boosts LC Solutions Portfolio With New Software

by Zacks Equity Research

Waters (WAT) unveils HPLC CONNECT software, bolstering its liquid chromatography solutions portfolio.

Should Invesco Bloomberg Pricing Power ETF (POWA) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for POWA

Waters (WAT) Q4 Earnings & Sales Beat Estimates, Fall Y/Y

by Zacks Equity Research

Waters' (WAT) fourth-quarter results reflect weak end-market momentum. Also, softness in Asia is concerning.

Waters (WAT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Waters (WAT) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Waters (WAT) delivered earnings and revenue surprises of 1.69% and 0.71%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Waters' (WAT) fourth-quarter 2023 results are likely to reflect strength in the large molecule market and Waters services business amid weakening demand in China.

What Analyst Projections for Key Metrics Reveal About Waters (WAT) Q4 Earnings

by Zacks Equity Research

Get a deeper insight into the potential performance of Waters (WAT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Why Is Waters (WAT) Up 13.2% Since Last Earnings Report?

by Zacks Equity Research

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Compared to Estimates, Waters (WAT) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Waters (WAT) Q3 Earnings Beat Estimates, Revenues Rise Y/Y

by Zacks Equity Research

Waters' (WAT) Q3 results benefit from a strong Pharmaceutical market, as well as a strong contribution from the Wyatt acquisition.

Curious about Waters (WAT) Q3 Performance? Explore Wall Street Estimates for Key Metrics

by Zacks Equity Research

Evaluate the expected performance of Waters (WAT) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Waters (WAT) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Waters' (WAT) third-quarter 2023 results are likely to reflect strength in liquid chromatography instruments and mass spectrometers amid uncertainties in the global economy.

Tactile Systems Technology (TCMD) Surges 5.8%: Is This an Indication of Further Gains?

by Zacks Equity Research

Tactile Systems Technology (TCMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

ClearPoint Neuro, Inc. (CLPT) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

ClearPoint Neuro, Inc. (CLPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Waters (WAT) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) Boosts Mass Spectrometry Clientele With Latest Move

by Zacks Equity Research

Waters (WAT) partners with the University of San Agustin to provide the latter with technology equipment in its newly developed mass spectrometry imaging center in the Philippines.

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development

by Zacks Equity Research

Waters (WAT) launches new bioprocess walk-up solutions, automating sample prep and analysis from any bioreactor.

Waters (WAT) Down 3.6% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Waters (WAT) Q2 Earnings & Sales Beat Estimates, Rise Y/Y

by Zacks Equity Research

Waters' (WAT) second-quarter results benefit from solid momentum in the industrial, and government and academic markets.

Waters (WAT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.